Literature DB >> 7711665

Accelerated and long-term hematopoietic engraftment in mice transplanted with ex vivo expanded bone marrow.

F Serrano1, F Varas, A Bernad, J A Bueren.   

Abstract

Using a murine experimental model, we investigated whether ex vivo expansion of BM grafts under IL-3/IL-6 stimulation accelerates the early hematopoietic recovery of recipients of BM transplants. To facilitate the ex vivo expansion of hematopoietic progenitors, BM was first enriched in proliferatively active hematopoietic stem cells by a single treatment with 5-fluorouracil (5FU) 4 days prior to the BM harvest. The results showed that the number of CFU-GM and CFU-S12 progenitors in the graft was significantly increased (56-fold and 14-fold, respectively), as a result of a 3 day incubation in the presence of IL-3 and IL-6. Daily analysis of animals transplanted with 5 x 10(4) BM cells, either freshly harvested or expanded for 3 days, showed that the expanded grafts consistently allowed a faster hematopoietic recovery of recipients. Differences between both groups of transplanted animals were most evident when the number of either femoral or splenic CFU-GMs were compared, with increases close to 70-fold at the fifth day of engraftment being observed. Similarly, mice transplanted with expanded grafts showed a hastened recovery in the cellularity of both organs that was most significant during the second week following transplantation, with maximal increases of 15 and 40-fold in the BM and spleen, respectively. Differences in peripheral leukocyte numbers between both groups of recipients were much less remarkable than those observed in the hematopoietic organs, although from the nadir period to the 11th day post-transplantation differences ranging from twofold to sixfold were apparent, consistent with a higher rate of mouse survival.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7711665

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  4 in total

1.  Acquired hematopoietic stem cell defects determine B-cell repertoire changes associated with aging.

Authors:  Lisa M Guerrettaz; Sara A Johnson; John C Cambier
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-12       Impact factor: 11.205

2.  IL-6 blocks a discrete early step in lymphopoiesis.

Authors:  Kazuhiko Maeda; Yoshihiro Baba; Yoshinori Nagai; Kozo Miyazaki; Alexander Malykhin; Koji Nakamura; Paul W Kincade; Nobuo Sakaguchi; K Mark Coggeshall
Journal:  Blood       Date:  2005-04-14       Impact factor: 22.113

3.  A Combined In Vivo HSC Transduction/Selection Approach Results in Efficient and Stable Gene Expression in Peripheral Blood Cells in Mice.

Authors:  Hongjie Wang; Maximilian Richter; Nikoletta Psatha; Chang Li; Jiho Kim; Jing Liu; Anja Ehrhardt; Susan K Nilsson; Benjamin Cao; Donna Palmer; Philip Ng; Zsuzsanna Izsvák; Kevin G Haworth; Hans-Peter Kiem; Thalia Papayannopoulou; André Lieber
Journal:  Mol Ther Methods Clin Dev       Date:  2017-11-10       Impact factor: 6.698

4.  Src homology 2-containing 5-inositol phosphatase (SHIP) suppresses an early stage of lymphoid cell development through elevated interleukin-6 production by myeloid cells in bone marrow.

Authors:  Koji Nakamura; Taku Kouro; Paul W Kincade; Alexander Malykhin; Kazuhiko Maeda; K Mark Coggeshall
Journal:  J Exp Med       Date:  2004-01-12       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.